Kenichi Furihata
- Pharmacokinetics (PK) of mometasone furoate and indacaterol in Japanese and Caucasian healthy subjects after once daily inhalation of QMF149By Sayaka Shimada, Soniya Vaidya, Sanjeev Khindri, Natsuka Tashiro, Beverley Patterson, Ralph Woessner, Kiyoshi Kobayashi and Kenichi FurihataSayaka Shimada1Translational Sciences, Novartis Pharma K.K., Tokyo, JapanSoniya Vaidya2Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Cambridge, United StatesSanjeev Khindri3Translational Medicine, Novartis Institutes for BioMedical Research, Horsham, United KingdomNatsuka Tashiro1Translational Sciences, Novartis Pharma K.K., Tokyo, JapanBeverley Patterson4Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Horsham, United KingdomRalph Woessner5Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Basel, SwitzerlandKiyoshi Kobayashi1Translational Sciences, Novartis Pharma K.K., Tokyo, JapanKenichi Furihata6P-one Clinic, Keikokai Medical Corporation, Tokyo, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.